Comparison | Â | Studies | Overall effect | Heterogeneity | ||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | Z score | p value | padjust | I2 (%) | p value | |||
CC vs. TC+TT | Overall | 7 | 0.94 (0.71, 1.24) | 0.43 | 0.667 | 1.000 | 51.6 | 0.054 |
Caucasian | 5 | 0.85 (0.65, 1.12) | 1.14 | 0.255 | 1.000 | 43.9 | 0.129 | |
African | 1 | 1.71 (0.07, 42.57) | 0.33 | 0.744 | 1.000 | - | - | |
Asian | 1 | 1.52 (1.01, 2.28) | 2.01 | 0.044 | 0.308 | - | - | |
Prostate cancer | 3 | 0.84 (0.60, 1.16) | 1.08 | 0.280 | 1.000 | 0 | 0.480 | |
Breast cancer | 2 | 1.01 (0.79, 1.30) | 0.11 | 0.911 | 1.000 | 0 | 0.560 | |
Colorectal cancer | 2 | 0.75 (0.17, 3.34) | 0.37 | 0.708 | 1.000 | 88.4 | 0.003 | |
TT vs. TC+CC | Overall | 7 | 1.13 (0.94, 1.36) | 1.30 | 0.192 | 1.000 | 74.3 | 0.001 |
Caucasian | 5 | 1.18 (1.01, 1.37) | 2.10 | 0.035 | 0.245 | 57.4 | 0.052 | |
African | 1 | 1.81 (0.86, 3.81) | 1.56 | 0.118 | 0.826 | - | - | |
Asian | 1 | 0.79 (0.65, 0.97) | 2.31 | 0.021 | 0.147 | - | - | |
Prostate cancer | 3 | 1.16 (0.81, 1.65) | 0.82 | 0.415 | 1.000 | 72.9 | 0.025 | |
Breast cancer | 2 | 1.19 (1.05, 1.36) | 2.70 | 0.007 | 0.049 | 0 | 0.479 | |
Colorectal cancer | 2 | 1.09 (0.56, 2.10) | 0.25 | 0.804 | 1.000 | 89.9 | 0.002 | |
CC vs. TT | Overall | 7 | 0.90 (0.66, 1.23) | 0.68 | 0.498 | 1.000 | 59.2 | 0.023 |
Caucasian | 5 | 0.81 (0.62, 1.06) | 1.55 | 0.121 | 0.847 | 40.2 | 0.153 | |
African | 1 | 1.49 (0.06, 37.34) | 0.24 | 0.808 | 1.000 | - | - | |
Asian | 1 | 1.64 (1.08, 2.48) | 2.33 | 0.020 | 0.140 | - | - | |
Prostate cancer | 3 | 0.81 (0.58, 1.13) | 1.23 | 0.218 | 1.000 | 0 | 0.787 | |
Breast cancer | 2 | 0.94 (0.73, 1.22) | 0.45 | 0.650 | 1.000 | 0 | 0.538 | |
Colorectal cancer | 2 | 0.71 (0.13, 4.05) | 0.38 | 0.703 | 1.000 | 91.1 | 0.001 | |
TC vs. TC+TT | Overall | 7 | 0.89 (0.74, 1.07) | 1.29 | 0.197 | 1.000 | 72.4 | 0.001 |
Caucasian | 5 | 0.86 (0.72, 1.02) | 1.76 | 0.079 | 0.553 | 63.5 | 0.027 | |
African | 1 | 0.52 (0.25, 1.11) | 1.69 | 0.091 | 0.637 | - | - | |
Asian | 1 | 1.21 (0.98, 1.49) | 1.80 | 0.073 | 0.511 | - | - | |
Prostate cancer | 3 | 0.86 (0.56, 1.32) | 0.71 | 0.479 | 3.353 | 80.4 | 0.006 | |
Breast cancer | 2 | 0.82 (0.72, 0.94) | 2.87 | 0.004 | 0.028 | 0 | 0.602 | |
Colorectal cancer | 2 | 0.95 (0.56, 1.60) | 0.21 | 0.834 | 1.000 | 83.5 | 0.014 | |
C vs. T | Overall | 7 | 0.91 (0.79, 1.06) | 1.24 | 0.217 | 1.000 | 73.3 | 0.001 |
Caucasian | 5 | 0.88 (0.79, 0.98) | 2.40 | 0.016 | 0.112 | 43.1 | 0.135 | |
African | 1 | 0.63 (0.32, 1.25) | 1.32 | 0.185 | 1.000 | - | - | |
Asian | 1 | 1.24 (1.06, 1.46) | 2.67 | 0.008 | 0.056 | - | - | |
Prostate cancer | 3 | 0.90 (0.74, 1.09) | 1.07 | 0.284 | 1.000 | 42.3 | 0.177 | |
Breast cancer | 2 | 0.89 (0.80, 0.99) | 2.14 | 0.033 | 0.231 | 0 | 0.344 | |
Colorectal cancer | 2 | 0.93 (0.51, 1.69) | 0.25 | 0.804 | 1.000 | 92.5 | <0.001 |